Crossmark

Effects of the ABC pathway on clinical outcomes in very elderly Chinese patients with atrial fibrillation. A report from the optimal thromboprophylaxis in elderly Chinese patients with atrial fibrillation (ChiOTEAF) registry

Crossref DOI link: https://doi.org/10.1007/s11739-025-03928-0

Published Online: 2025-04-27

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fawzy, Ameenathul Mazaya

Kotalczyk, Agnieszka

Guo, Yutao

Wang, Yutang

Lip, Gregory Y. H. https://orcid.org/0000-0002-7566-1626
,
License Information

Text and Data Mining valid from 2025-04-27

Version of Record valid from 2025-04-27
More Information

Article History

Received: 30 October 2024

Accepted: 17 March 2025

First Online: 27 April 2025

Declarations

:

: GYHL—Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo. No fees are directly received personally. He is co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 899871. The rest of the authors have none to declare.

: This study was performed in line with the principles of the Declaration of Helsinki. Ethics approval was granted by the Central Medical Ethic Committee of Chinese PLA General Hospital (approval no S2014-065-01).

: Written informed consent was obtained from all individual participants included in the study.

: Not applicable.Authors are responsible for correctness of the statements provided in the manuscript.

Document is current

Any future updates will be listed below